高级检索
产气肠杆菌突变株EAM-Z1的培养和核苷磷酸化酶活力的研究[J]. 中国药科大学学报, 2003, (2): 85-87.
引用本文: 产气肠杆菌突变株EAM-Z1的培养和核苷磷酸化酶活力的研究[J]. 中国药科大学学报, 2003, (2): 85-87.
Studies on the Culture Conditions of E. aerogenes Mutant EAM-Z1 and its Phosphorylase Activity[J]. Journal of China Pharmaceutical University, 2003, (2): 85-87.
Citation: Studies on the Culture Conditions of E. aerogenes Mutant EAM-Z1 and its Phosphorylase Activity[J]. Journal of China Pharmaceutical University, 2003, (2): 85-87.

产气肠杆菌突变株EAM-Z1的培养和核苷磷酸化酶活力的研究

Studies on the Culture Conditions of E. aerogenes Mutant EAM-Z1 and its Phosphorylase Activity

  • 摘要: 目的:大规模培养具有高活力核苷磷酸化酶的产气肠杆菌突变株(E.aerogenes EAM-Z1),利用静息细胞酶法合成抗肿瘤核苷药物中间体5—氟尿苷(FUR)。方法:补料分批培养产气肠杆菌,发酵过程流加葡萄糖、控制发酵液的pH和pO2,摇瓶培养基中加入底物胞苷诱导核苷磷酸化酶,通过酶法合成FUR时菌体对底物尿苷的转化率来研究菌体的核苷磷酸化酶活力。结果:葡萄糖既可满足产气肠杆菌碳源的需要,又能维持培养液的pH,培养24h发酵液菌体温重为19.1g/L,以尿苷(UR)和5—氟尿嘧啶(FU)为底物,产气肠杆菌游离湿菌体对UR的酶转化率为56.7%;摇瓶培养基中加入3.0g/L胞苷诱导核苷磷酸化酶,静息细胞的酶转化率提高了10.2%;酶反应间隙流加底物UR浓度达30mmol/L时,产物FUR的浓度最高,进一步增加底物浓度则抑制产物的合成。结论:通过大规模培养可获得产高活力核苷磷酸化酶的产气肠杆菌,其静息细胞可用于抗肿瘤核苷药物中间体FUR的制备。

     

    Abstract: The purpose is to obtain E. aerogene s mutant EAM Z1 resting cells with high nucleoside phosphorylase activity on scale and to apply to the biosyn the sis of 5 fluor uridine which is an important intermediate of anticancer drug(f ur tulon). E. ae

     

/

返回文章
返回